SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer
暂无分享，去创建一个
A. Prat | P. Villagrasa | B. González-Farré | J. M. Ferrero-Cafiero | M. Muñoz | C. Saura | J. Cejalvo | E. Ciruelos | Mafalda Oliveira | M. Vidal | J. Gavilá | T. Pascual | L. Paré | P. Fan | M. Espinosa-Bravo | J. Cruz | S. Pernas | G. Villacampa | J. Guerra | O. Martínez-Sáez | S. Esker | M. Bellet Ezquerra | M. Margeli Vila | Francisco Javier Salvador-Bofill | A. M. Luna Barrera | M. Arumi de Dios | F. J. Salvador-Bofill